期刊文献+

syndecan-1在结直肠癌中的表达及意义 被引量:6

Syndecan-1 Protein Expression in Colorectal Cancer
下载PDF
导出
摘要 目的研究syndecan-1在结直肠癌中的表达,探讨它与肿瘤生长和预后的关系。方法采用免疫组织化学染色技术,检测syndecan-1在结直肠癌及其周围正常组织中的表达,初步分析它与结直肠癌临床病理特征和临床预后的关系。结果31例肿瘤组织切片中,syndecan-1表达阳性者仅1例(3.2%),正常组织中syndecan-1表达阳性者29例(93.5%),syndecan-1表达阳性率在两组间的差异有统计学意义(P<0.01)。syndecan-1主要表达在正常肠黏膜上皮,肿瘤间质中的表达呈弱阳性。结论syndecan-1主要表达在正常结直肠黏膜上皮,肿瘤细胞中极少表达。 Objective Heparan sulfate proteoglycans (HSPGs) is an important component of the extracellular matrix, syndecan-1, a member of syndecan family, belongs to HSPGs and plays an important role in cell morphology and intracellular arrangement. The present study was designed to investigate the expression of syndecan-1 in patients with colorectal cancer, to analyse its relationship to cancer progression and clinical prognosis. Methods Paraffin-embeded specimens were collected from 31 patients with colorectal cancers from 2003 to 2004 in Peking Union Medical College Hospital. Syndecan-1 protein expression was measured by immunohistochemistry. Its expression was evaluated with relationship to clinicopathological factors, including tumor infiltration, tumor differentiation, lymph node metastasis, accompanying with colorectal adenoma and 2-year survivals. Results Immunohistochemistry in 31 specimens showed syndecan-1 were detected positive in 1 colorectal cancer tissue (3.2%), while positive in 29 normal tissues (93.5%), with significant difference (P〈0.01). No prognostic differences could be found in the clinic outcome because of the high expression rate of syndecan-1 in normal tissues and low expression rate in cancer tissues. Conclusion Syncecan-1 is expressed in normal colorectal tissues and rarely expressed in cancer tissues.
出处 《中国普外基础与临床杂志》 CAS 2007年第3期320-323,共4页 Chinese Journal of Bases and Clinics In General Surgery
关键词 SYNDECAN-1 结直肠癌 预后 Syndecan-1 Colorectal cancer Prognosis
  • 相关文献

参考文献14

  • 1Day RM,Hao X,Ilyas M,et al.Changes in the expression of syndecan-1 in the colorectal adenoma-carcinoma sequence[J].Virchows Arch,1999;434(2):121
  • 2Conejo JR,Kleeff J,Koliopanos A,et al.Syndecan-1 expression is up-regulated in pancreatic but not in other gastrointestinal cancers[J].Int J Cancer,2000;88(1):12
  • 3王学浩,成峰,钱建民,张峰,李相成.syndecan-1蛋白的表达与肝细胞肝癌恶性表型的研究[J].中国普外基础与临床杂志,2001,8(4):239-241. 被引量:3
  • 4Greene FL,Page DL,Fleming ID,et al Eds.AJCC Cancer Staging Manual[M].6th Ed.New York:Springer,2002:113~119
  • 5Mikami S,Ohashi K,Usui Y,et al.Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas[J].Jpn J Cancer Res,2001;92(10):1062
  • 6Beauvais DM,Rapraeger AC.Syndecans in tumor cell adhesion and signaling[J].Reprod Biol Endocrinol,2004;2:3
  • 7Pulkkinen JO,Penttinen M,Jalkanen M,et al.Syndecan-1:a new prognostic marker in laryngeal cancer[J].Acta Otolaryngol,1997;117(2):312
  • 8Wiksten JP,Lundin J,Nordling S,et al.Epithelial and stromal syndecan-1 expression as predictor of outcome in patients with gastric cancer[J].Int J Cancer,2001;95(1);1
  • 9Joensuu H,Anttonen A,Eriksson M,et al.Soluble syndecan-l and serum basic fibroblast growth factor are new prognostic factors in lung cancer[J].Cancer Res,2002;62(18):5210
  • 10Lundin M,Nordling S,Lundin J,et al.Epithelial syndecan-l expression is associated with stage and grade in colorectal cancer[J].Oncology,2005;68(4-6):306

二级参考文献10

  • 1赵仲生,姚根有,茹国庆,马杰,阮俊.碱性成纤维细胞生长因子和基质金属蛋白酶-9mRNA表达与胃癌临床病理学及生存期的关系[J].中华外科杂志,2005,43(3):169-173. 被引量:6
  • 2Bernfield M,Kokenyesi P,Kato M,et al.Biology of the syndecans〔J〕[].Annual Review of Biochemistry.1992
  • 3Inki P,Joensuu H,Grenman R,et al.Association between syndecan-1 expression and clinical outcome in squamous cell carcinoma of the head and neck 〔J〕[].British Journal of Cancer.1994
  • 4Roskams T,Moshage H,De Vos R,et al.Heparan sulfate proteoglycan expression in normal human liver 〔J〕[].Hepatology.1995
  • 5Roskams T,De Vos R,David G,et al.Heparan sulphate proteoglycan expression in human primary liver tumors 〔J〕[].Journal of Paleopathology.1998
  • 6Kumar-Singh S,Jacobs W,Dhaene K,et al.Syndecan-1 expression in maligant mesothlioma: correlation with differentiation, wtl expression,and clinical outcome 〔J〕[].Journal of Paleopathology.1998
  • 7Mali M,Andfolk H,Miettinen HM,et al.Suppression of tumor cell growth by syndecan-1 ectodomain 〔J〕[].Journal of Biological Chemistry.1994
  • 8Izumi R,Shimizu K,Li T,et al.Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection 〔 J 〕[].Gastroenterology.1994
  • 9Matsumoto A,Ono M,Fujimoto Y,et al.Reduced expression of syndecan-1 in human hepatocellular carcinoma with high metastatic potential 〔J〕[].International Journal of Cancer.1997
  • 10Jun-QiangChen Wen-HuaZhan Yu-LongHe Jun-ShengPeng Jian-PingWang Shi-RongCai Jin-PingMa.Expression of heparanase gene,CD44v6,MMP-7 and nm23 protein and their relationship with the invasion and metastasis of gastric carcinomas[J].World Journal of Gastroenterology,2004,10(6):776-782. 被引量:123

共引文献11

同被引文献27

引证文献6

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部